<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">UBE3A — Ubiquitin Protein Ligase E3A</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>UBE3A</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Ubiquitin Protein Ligase E3A</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>15q11-q13</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>853 amino acids (~100 kDa)</td>
</tr>
<tr>
<td class="label">Primary Function</td>
<td>E3 ubiquitin ligase; protein quality control</td>
</tr>
<tr>
<td class="label">Expression Pattern</td>
<td>Ubiquitous; highly expressed in neurons</td>
</tr>
</table>
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">UBE3A — Ubiquitin Protein Ligase E3A</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>UBE3A</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Ubiquitin Protein Ligase E3A</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>15q11-q13</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>853 amino acids (~100 kDa)</td>
</tr>
<tr>
<td class="label">Primary Function</td>
<td>E3 ubiquitin ligase; protein quality control</td>
</tr>
<tr>
<td class="label">Expression Pattern</td>
<td>Ubiquitous; highly expressed in neurons</td>
</tr>
</table>
The UBE3A gene encodes a HECT-class (Homologous to E6-AP Carboxyl Terminus) E3 ubiquitin ligase, also known as E6-associated protein (E6AP). Located on chromosome 15q11-q13 within the Prader-Willi syndrome critical region, UBE3A functions as a critical regulator of protein stability and cellular homeostasis. The protein is ubiquitously expressed across tissues but demonstrates particularly high abundance in the nervous system, where it plays essential roles in synaptic function, neuronal development, and protein quality control. UBE3A was historically recognized through its interaction with the human papillomavirus E6 protein, though its physiological functions extend far beyond viral pathogenesis. The gene exhibits parent-of-origin-dependent expression in certain tissues, particularly in the brain, where the maternal allele is preferentially expressed due to paternal imprinting—a feature with significant implications for associated neurological disorders.
UBE3A encodes a HECT-domain E3 ligase that catalyzes the covalent attachment of ubiquitin polymers to target proteins through a two-step enzymatic mechanism. The protein contains distinct functional domains: an N-terminal region conferring substrate specificity, a central HERC domain, and a C-terminal HECT domain responsible for ubiquitin conjugation. Through this activity, UBE3A mediates the polyubiquitination of diverse substrates, primarily generating K48-linked ubiquitin chains that target proteins for proteasomal degradation.
Key substrates of UBE3A include the tumor suppressor protein p53, the synaptic protein Arc (Activity-regulated cytoskeleton-associated protein), and various glutamate receptor subunits. In the synaptic compartment, UBE3A specifically regulates AMPA-type glutamate receptors (AMPARs), influencing receptor trafficking and synaptic strength. The enzyme also participates in the ubiquitin proteasome system (UPS), a major protein quality control pathway essential for eliminating misfolded or damaged proteins.
UBE3A activity is tightly regulated through phosphorylation, protein-protein interactions, and subcellular localization. The protein localizes to multiple cellular compartments including the cytoplasm, nucleus, and synaptic terminals, allowing compartmentalized regulation of diverse cellular processes. Synaptic activity regulates UBE3A function through calcium/calmodulin-dependent kinase pathways, enabling activity-dependent protein degradation critical for synaptic plasticity.
While UBE3A dysfunction is primarily recognized in developmental and neurodevelopmental disorders, emerging evidence implicates UBE3A dysregulation in neurodegeneration. Loss-of-function mutations and reduced UBE3A expression impair the cellular ability to eliminate misfolded proteins, potentially exacerbating accumulation of pathogenic protein aggregates characteristic of neurodegenerative diseases. The protein's central role in regulating AMPAR trafficking directly impacts glutamatergic synaptic transmission; aberrant UBE3A activity contributes to excitotoxicity and neuronal loss.
Reduced UBE3A activity has been detected in post-mortem brain tissue from individuals with Alzheimer's disease and Parkinson's disease, correlating with cognitive decline and motor dysfunction. In animal models, UBE3A haploinsufficiency exacerbates neuroinflammation and accelerates neuronal death in contexts of proteotoxic stress. Conversely, UBE3A overexpression shows neuroprotective effects in some experimental paradigms by enhancing clearance of disease-associated proteins.
UBE3A catalyzes proteasomal degradation of Arc, a protein crucial for
The following diagram shows the key molecular relationships involving UBE3A Gene discovered through SciDEX knowledge graph analysis: